Cogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%

MT Newswires Live

01/22

Cogstate (ASX:CGS) reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.

The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.

The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.

Shares of the company rose past 7% in recent Thursday trade.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2605437866"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2605437866\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2605437866?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-22 08:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605437866","market":"us","top_or_hot":-1,"title":"Cogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%","media":"MT Newswires Live","content":"<html><body><p> Cogstate (ASX:CGS) reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.</p><p>The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.</p><p>The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.</p><p>Shares of the company rose past 7% in recent Thursday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-22 08:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Cogstate (ASX:CGS) reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.</p><p>The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.</p><p>The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.</p><p>Shares of the company rose past 7% in recent Thursday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7094","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2605437866","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605437866","pubTimestamp":1769043263,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cogstate  reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.Shares of the company rose past 7% in recent Thursday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7094":"医疗保健技术","CGS.AU":"COGSTATE LTD"},"translate_title":"Cogstate公布上半年财政收入、临床试验合同价值更高；股价上涨7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGS.AU":1},"content_text":"Cogstate (ASX:CGS) reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.Shares of the company rose past 7% in recent Thursday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}